Arvinas
ARVN
#6008
Rank
HK$7.48 B
Marketcap
HK$101.93
Share price
-1.65%
Change (1 day)
-47.72%
Change (1 year)

P/E ratio for Arvinas (ARVN)

P/E ratio as of December 2025 (TTM): -16.2

According to Arvinas's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -16.1728. At the end of 2024 the company had a P/E ratio of -6.92.

P/E ratio history for Arvinas from 2018 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024-6.929.29%
2023-6.33-1.53%
2022-6.43-70.17%
2021-21.6-24.1%
2020-28.445.86%
2019-19.51233.06%
2018-1.46

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
ORIC Pharmaceuticals
ORIC
-5.86-63.76%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.